Becker's Healthcare April 29, 2024
Pfizer’s first FDA-approved gene therapy is one of the most expensive medications in the U.S.
On April 26, Beqvez (fidanacogene elaparvovec-dzkt) won approval to treat some adults with moderate-to-severe hemophilia B. The drugmaker set the list price at $3.5 million,...